ES2154610B1 - Nuevas actividades farmacologicas de los extractos de curcuma longa. - Google Patents

Nuevas actividades farmacologicas de los extractos de curcuma longa.

Info

Publication number
ES2154610B1
ES2154610B1 ES009902364A ES9902364A ES2154610B1 ES 2154610 B1 ES2154610 B1 ES 2154610B1 ES 009902364 A ES009902364 A ES 009902364A ES 9902364 A ES9902364 A ES 9902364A ES 2154610 B1 ES2154610 B1 ES 2154610B1
Authority
ES
Spain
Prior art keywords
pharmacological activities
curcuma longa
new pharmacological
longa extracts
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009902364A
Other languages
English (en)
Other versions
ES2154610A1 (es
Inventor
Almagro Eliseo Quintanilla
Bosca Ana Ramirez
August Bernd
Zapata Jose Pardo
Alperi Joaquin Diaz
Mira David Pamies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASAC Compania de Biotecnologia e Investigacion SA
Original Assignee
ASAC Compania de Biotecnologia e Investigacion SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASAC Compania de Biotecnologia e Investigacion SA filed Critical ASAC Compania de Biotecnologia e Investigacion SA
Priority to ES200003146A priority Critical patent/ES2154615B1/es
Priority to ES009902364A priority patent/ES2154610B1/es
Priority to ES200000396A priority patent/ES2157862B1/es
Priority to US09/856,035 priority patent/US6841177B1/en
Priority to DE60043609T priority patent/DE60043609D1/de
Priority to JP2001524611A priority patent/JP2003509464A/ja
Priority to PCT/ES2000/000354 priority patent/WO2001021185A1/es
Priority to AU75253/00A priority patent/AU7525300A/en
Priority to AT00964281T priority patent/ATE453398T1/de
Priority to EP00964281A priority patent/EP1133992B1/en
Priority to CA002351482A priority patent/CA2351482A1/en
Publication of ES2154610A1 publication Critical patent/ES2154610A1/es
Application granted granted Critical
Publication of ES2154610B1 publication Critical patent/ES2154610B1/es
Priority to US10/684,452 priority patent/US7220438B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nuevas actividades farmacológicas de los extractos de Curcuma Longa como agente antiproliferativo y actividad fotosensibilizante y su uso en una composición farmacéutica como agente en patologías proliferativas.
ES009902364A 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos de curcuma longa. Expired - Fee Related ES2154610B1 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES200003146A ES2154615B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos del curcuma longa.
ES009902364A ES2154610B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos de curcuma longa.
ES200000396A ES2157862B1 (es) 1999-09-23 2000-02-10 Adicion a la patente principal numero 9902364 con titulo "nuevas actividades farmacologicas de los extractos del curcuma longa"
AU75253/00A AU7525300A (en) 1999-09-23 2000-09-21 Novel pharmacological activities of curcuma longa extracts
JP2001524611A JP2003509464A (ja) 1999-09-23 2000-09-21 ウコン抽出物の新規の薬理活性
PCT/ES2000/000354 WO2001021185A1 (es) 1999-09-23 2000-09-21 Nuevas actividades farmacologicas de los extractos de curcuma longa
US09/856,035 US6841177B1 (en) 1999-09-23 2000-09-21 Pharmacological activities of curcuma longa extracts
AT00964281T ATE453398T1 (de) 1999-09-23 2000-09-21 Neuartige pharmakologische aktivitäten von curcuma longa extrakten
EP00964281A EP1133992B1 (en) 1999-09-23 2000-09-21 Novel pharmacological activities of curcuma longa extracts
CA002351482A CA2351482A1 (en) 1999-09-23 2000-09-21 Novel pharmacological activities of curcuma longa extracts
DE60043609T DE60043609D1 (de) 1999-09-23 2000-09-21 Neuartige pharmakologische aktivitäten von curcuma longa extrakten
US10/684,452 US7220438B2 (en) 1999-09-23 2003-10-15 Pharmacological activities of Curcuma longa extracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009902364A ES2154610B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos de curcuma longa.

Publications (2)

Publication Number Publication Date
ES2154610A1 ES2154610A1 (es) 2001-04-01
ES2154610B1 true ES2154610B1 (es) 2001-11-16

Family

ID=8310389

Family Applications (3)

Application Number Title Priority Date Filing Date
ES009902364A Expired - Fee Related ES2154610B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos de curcuma longa.
ES200003146A Expired - Fee Related ES2154615B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos del curcuma longa.
ES200000396A Expired - Fee Related ES2157862B1 (es) 1999-09-23 2000-02-10 Adicion a la patente principal numero 9902364 con titulo "nuevas actividades farmacologicas de los extractos del curcuma longa"

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES200003146A Expired - Fee Related ES2154615B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos del curcuma longa.
ES200000396A Expired - Fee Related ES2157862B1 (es) 1999-09-23 2000-02-10 Adicion a la patente principal numero 9902364 con titulo "nuevas actividades farmacologicas de los extractos del curcuma longa"

Country Status (9)

Country Link
US (1) US6841177B1 (es)
EP (1) EP1133992B1 (es)
JP (1) JP2003509464A (es)
AT (1) ATE453398T1 (es)
AU (1) AU7525300A (es)
CA (1) CA2351482A1 (es)
DE (1) DE60043609D1 (es)
ES (3) ES2154610B1 (es)
WO (1) WO2001021185A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357811B1 (en) * 2001-02-09 2008-10-08 New Chapter, Inc. Composition and method for smoke detoxification
US9265808B2 (en) 2004-03-23 2016-02-23 Lifeline Nutraceuticals Corporation Compositions for alleviating inflammation and oxidative stress in a mammal
EP1740196B1 (en) * 2004-03-23 2015-08-26 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal
BRPI0621872A2 (pt) * 2006-07-19 2012-10-16 Universidad De Guadalajara métodos para preparar um fármaco em suspensão e em cápsulas para uso pediátrico e para adulto a base de curcumina, formulação e fármacos em suspensão e em cápsulas para o tratamento de uma infecção parasitária causada por giárdia lamblia e métodos para tratar um infecção parasitária provocada por giárdia lamblia
CN101686725A (zh) 2007-04-03 2010-03-31 刚迦·拉贾·高卡拉贾 消炎和抗氧化协同作用的膳食补充组合物
JP5486744B2 (ja) * 2007-10-03 2014-05-07 サベル コーポレーション ムユヨの花、トゲバンレイシの葉、及びウコンの根の抽出物を含む、肝炎を治療するための組成物
WO2009066303A2 (en) 2007-11-22 2009-05-28 Ganga Raju Gokaraju New synergistic phytochemical composition for the treatment of obesity
JP6062616B2 (ja) * 2007-12-21 2017-01-18 アサク コンパーニャ デ ビオテクノロヒア エ インベスティガシオン，ソシエダ アノニマ クルクミノイド及びこれらの類似体の治療有効性を改善するための方法
WO2009080842A1 (es) * 2007-12-21 2009-07-02 Asac Compañía De Biotecnología E Investigación Sa Composiciones fotoprotectoras
MY174568A (en) * 2013-12-31 2020-04-27 Sirim Berhad A bioactive composition having natural uv photoprotective properties
CN104888098A (zh) * 2015-05-04 2015-09-09 孙著叶 一种用于关节置换后静脉血栓的中药制剂及制备方法
KR20220041945A (ko) * 2017-07-24 2022-04-01 새미-사빈사 그룹 리미티드 사용된 강황 - 이의 방법 및 조성물
CN107596252A (zh) * 2017-09-04 2018-01-19 中国科学院化学研究所 姜黄提取物及其制备方法、用途和保健品
JP6709001B1 (ja) * 2019-07-01 2020-06-10 ハウスウェルネスフーズ株式会社 ＴＮＦ−α又はＩＬ−６産生抑制用組成物
KR102327827B1 (ko) * 2019-11-01 2021-11-18 한국과학기술연구원 강황 추출물을 유효성분으로 포함하고 자외선 처리를 포함하는 건선 개선용 조성물
FR3104947B1 (fr) * 2019-12-18 2022-11-25 Fabre Pierre Dermo Cosmetique Extrait de Curcuma longa sans curcuminoïde, dans les dermatoses inflammatoires
CN111166847B (zh) * 2019-12-23 2021-12-31 成都锦华药业有限责任公司 一种含姜黄的药物组合物及其片剂和制备方法
RU2760551C1 (ru) * 2020-06-17 2021-11-29 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ лечения радиационных поражений организма и способ получения биологического препарата для лечения радиационных поражений организма
CN117771223A (zh) * 2023-03-01 2024-03-29 孙良丹 化合物或其药用衍生物在抑制aim2蛋白活性中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
PT726074E (pt) * 1994-08-03 2003-10-31 A C Pharmaceutical Internation Metodo de obtencao de extractos apolares e polares de curcuma e a sua aplicacao
US5891924A (en) * 1996-09-26 1999-04-06 Research Development Foundation Curcumin (diferuloylmethane) inhibition of NFκB activation
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US20020164374A1 (en) * 1997-10-29 2002-11-07 John Jackson Polymeric systems for drug delivery and uses thereof

Also Published As

Publication number Publication date
ES2154615A1 (es) 2001-04-01
DE60043609D1 (de) 2010-02-11
EP1133992B1 (en) 2009-12-30
ES2154615B1 (es) 2001-11-16
CA2351482A1 (en) 2001-03-29
JP2003509464A (ja) 2003-03-11
ES2154610A1 (es) 2001-04-01
ES2157862B1 (es) 2002-03-01
ES2157862A1 (es) 2001-08-16
EP1133992A1 (en) 2001-09-19
WO2001021185A1 (es) 2001-03-29
ATE453398T1 (de) 2010-01-15
US6841177B1 (en) 2005-01-11
AU7525300A (en) 2001-04-24

Similar Documents

Publication Publication Date Title
ES2154610B1 (es) Nuevas actividades farmacologicas de los extractos de curcuma longa.
GT199800136A (es) Formas de dosificacion farmaceuticas solidas.
PY950041A (es) Compuesto de 1- fenil 3-dimetilamino- propano a procedimientos para su preparacion y a la aplicacion de estas sustancias en farmacologia
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
SV1995000083A (es) Articulo absorbente con contenedor mejorado de heces
ATE527242T1 (de) Piperazin derivate und deren anwendung als therapeutische wirkstoffe
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
IT1274034B (it) Composizioni farmaceutiche a base di gomma da masticare e procedimento per la loro preparazione
AR015493A1 (es) DERIVADOS CICLOHEXILOS , COMPOSICIONES FARMACÉUTICAS Y EL USO DE LOS MISMOS PARA LA MANUFACTURA DE UNA COMPOSICIoN uTIL PARA INHIBIR LA ACTIVIDAD IN VITRO DE NEURAMINIDASA Y PARA EL TRATAMIENTO O PROFILAXIS DE LA INFECCIoN DE INFLUENZA Y PARA TRATAIMIENTO, Y UN MÉTODO IN VITRO PARA INHIBIR LA ACTIVI
ES2187079T3 (es) Nuevos conjugados colorante-polisacarido y su uso como agente de diagnostico.
ATE284399T1 (de) Chinolinpropyl-piperidinderivate und deren verwendung als antibakterielle wirkstoffe
BR9915247B1 (pt) compostos biaromáticos análogos da vitamina d, seus usos, composição farmacêutica e composição cosmética contendo os mesmos, e uso da composição cosmética.
MX229282B (es) Soluciones de almidon modificado y su uso en el cuidado personal.
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
DE60003938D1 (de) Wirkstoffe in hydrogel-mikroperlen
EE03858B1 (et) Konjugaadid, nende kasutamine eesnäärmevähi ravimites, farmatseutiline kompositsioon ja selle valmistamine
DE69808126D1 (de) Mentholderivate und ihre anwendung als erfrischungsmittel
ITMI951367A0 (it) Derivati della colchicina loro uso e formulazioni che li contengono
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
PT946566E (pt) Formas pro-farmacos e analogos da camptotecina sua aplicacao como medicamentos
DE69704060D1 (de) Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung
ES2147163A1 (es) Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.
FR2802806B1 (fr) Composition longue tenue structuree par un polymere et un corps gras pateux
AR023699A1 (es) Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
ES2180737T3 (es) Conjugado para la dosificacion individual de medicamentos, su procedimiento de preparacion y su uso en los mismos.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010401

Kind code of ref document: A1

Effective date: 20010401

FD2A Announcement of lapse in spain

Effective date: 20190520

FD2A Announcement of lapse in spain

Effective date: 20190603